CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 279 filers reported holding CUBIST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,228,000 | -73.0% | 12,200 | -82.2% | 0.01% | -74.1% |
| Q3 2014 | $4,556,000 | -43.5% | 68,685 | -40.5% | 0.05% | -42.6% |
| Q2 2014 | $8,063,000 | -6.2% | 115,485 | -1.7% | 0.09% | -6.9% |
| Q1 2014 | $8,594,000 | -4.7% | 117,480 | -10.3% | 0.10% | -3.8% |
| Q4 2013 | $9,017,000 | -13.6% | 130,930 | -20.3% | 0.10% | +10.5% |
| Q3 2013 | $10,436,000 | +23.4% | 164,190 | -6.2% | 0.10% | +18.8% |
| Q2 2013 | $8,456,000 | – | 175,120 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Quinn Opportunity Partners LLC | 328,000 | $33,013,000 | 15.74% |
| Cheyne Capital Management (UK) LLP | 373,372 | $37,593,000 | 9.88% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 897,136 | $90,296,000 | 9.71% |
| Andromeda Capital LLC | 76,760 | $7,726,000 | 9.71% |
| Palo Alto Investors LP | 1,303,668 | $131,214,000 | 7.70% |
| Andromeda Capital LLC | 50,000 | $5,033,000 | 6.32% |
| QVT Financial LP | 1,200,000 | $120,780,000 | 6.04% |
| HARVEST MANAGEMENT LLC | 42,500 | $4,278,000 | 6.03% |
| Sandell Investment Services LLC | 58,525 | $5,891,000 | 5.62% |
| Kellner Capital, LLC | 70,200 | $7,066,000 | 4.83% |